The goal of this study was to determine the sensitivity, specificity, and accuracy of transrectal ultrasound (TRUS) in comparison to magnetic resonance imaging (MRI) in the evaluation of tumor volume, early parametrial infiltration, and identification of residual tumor in early-stage cervical cancer. Patients in whom an early-stage cervical cancer was diagnosed by clinical examination were enrolled in the study. Only those patients who were examined by both MRI and TRUS with following surgical treatment were included. Imaging results were compared with pathology findings. Altogether, 120 patients were consecutively enrolled from January 2004 to February 2006. Data from 95 patients were evaluated. Correlation coefficient for TRUS- and MRI-derived volumes versus volumes at pathology reached R = 0.996 and R = 0.980, respectively. The accuracy for detecting tumor in 95 patients was 93.7% for TRUS and 83.2% for MRI (P

Department of Obstetrics and Gynecology Oncogynecological Center General Teaching Hospital Charles University Prague Czech Republic

Citace poskytuje Crossref.org

Magnetic resonance imaging and ultrasound examination in preoperative pelvic staging of early-stage cervical cancer: post-hoc analysis of SENTIX study

The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023)

Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer

Tumour-free distance: a novel prognostic marker in patients with early-stage cervical cancer treated by primary surgery

What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?

Ultrasound in gynecological cancer: is it time for re-evaluation of its uses?

The role of trachelectomy in cervical cancer